Creative Planning
ANAB icon

Creative Planning’s AnaptysBio ANAB Stock Holding History

Creative Planning’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
18,773
+1,937
+12% +$117K ﹤0.01% 2452
2026
Q1 		$934K Buy
16,836
+1,582
+10% +$85.1K ﹤0.01% 2523
2025
Q4 		$740K Sell
15,254
-1,453
-9% -$56.6K ﹤0.01% 2518
2025
Q3 		$512K Sell
16,707
-147
-0.9% -$3.37K ﹤0.01% 2699
2025
Q2 		$374K Buy
16,854
+3,571
+27% +$74.7K ﹤0.01% 2714
2025
Q1 		$247K Buy
+13,283
New +$222K ﹤0.01% 2897
2019
Q3 		– Sell
-3,622
Closed -$204K – 1991
2019
Q2 		$204K Buy
3,622
+3
+0.1% +$216 ﹤0.01% 1609
2019
Q1 		$264K Hold
3,619
– – ﹤0.01% 1401
2018
Q4 		$231K Hold
3,619
– – ﹤0.01% 1389
2018
Q3 		$361K Hold
3,619
– – ﹤0.01% 1282
2018
Q2 		$257K Buy
+3,619
New +$304K ﹤0.01% 1457

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Creative Planning's ANAB Position: Q2 2026 in Review

Creative Planning increased its AnaptysBio (ANAB) stake by 12% in Q2 2026, buying an estimated $117K and bringing the position to 18,773 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2452.

Creative Planning first reported a position in ANAB in Q2 2018 and has held it in 11 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Creative Planning held 18,773 shares of AnaptysBio worth $1.27M as of Q2 2026.
  • Creative Planning bought 1,937 AnaptysBio shares in Q2 2026, an estimated $117K.
  • AnaptysBio made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2452 holding.
  • Creative Planning first reported a position in AnaptysBio in Q2 2018 and has held it in 11 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.